When sizing clinical studies, it is important to consider a variety of options regarding sample size, including the assumptions made, the risks that are acceptable and how best to balance speed and cost with these risks. The exact focus will depend upon the phase of development and the disease area, and DaneStat can work with you to help define these aspects.



With over 20 years’ experience designing clinical trials, DaneStat can work with you to understand how important the aspects of speed, cost and risk are to your study

DaneStat can then provide sample size options (and associated risks) and work with you to assess which is the most appropriate for you.